The pharma industry’s reputation dropped slightly again among patient groups, largely due to drug pricing issues.

World at Workcategory Exclusive: US FDA asks some fired pharma user fee negotiation staff to return May 2, 2025 Healthcare & Pharmaceuticalscategory US judge allows testimony that Abbott and Mead ...

Baxter International, a prominent health care and pharmaceutical manufacturer, reports that President Trump's tariffs will ...

Cardinal Health’s Mike Brown, vice president of managed services, and Michelle Dalton, regional director of account ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. | For the second year in a row, the pharmaceutical industry has dipped ...

The Trump administration’s threat of pharmaceutical tariffs could risk ... But in the labyrinthian U.S. health care system, a chaotic mix of regulations, stakeholders and deals will determine ...

Healthcare and pharmaceutical sector projects make major strides under Vibrant Gujarat initiative: Dr H G Koshia: Shardul Nautiyal, Mumbai Friday, May 2, 2025, 08:00 Hrs [IST] The ...